Log in

GW Pharmaceuticals Stock Price, News & Analysis (LON:GWP)

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.32 million shs
Average Volume956,721 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive GWP News and Ratings via Email

Sign-up to receive the latest news and ratings for GWP and its competitors with MarketBeat's FREE daily newsletter.

GW Pharmaceuticals (LON:GWP) Frequently Asked Questions

What is GW Pharmaceuticals' stock symbol?

GW Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "GWP."

Has GW Pharmaceuticals been receiving favorable news coverage?

News articles about GWP stock have been trending somewhat positive this week, InfoTrie reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. GW Pharmaceuticals earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for GW Pharmaceuticals.

What other stocks do shareholders of GW Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include GW Pharmaceuticals PLC- (GWPH), Canopy Growth (CGC), Cronos Group (CRON), Immunomedics (IMMU), Cara Therapeutics (CARA), NVIDIA (NVDA), Aurora Cannabis (ACB), Insys Therapeutics (INSY), Alibaba Group (BABA) and Terra Tech (TRTC).

Who are GW Pharmaceuticals' key executives?

GW Pharmaceuticals' management team includes the folowing people:
  • Geoffrey W. Guy, Executive Chairman of the Board
  • Justin Gover, Chief Executive Officer, Director
  • Adam David George, Chief Financial Officer, Company Secretary, Director
  • Christopher John Tovey, Chief Operating Officer, Executive Director
  • Julian S. Gangolli, Executive Director
  • James Julian Noble, Non-Executive Deputy Chairman of the Board, Senior Independent Director
  • Cabot Brown, Non-Executive Independent Director
  • Thomas Gerard Lynch, Non-Executive Independent Director
  • Catherine J. Mackey Ph.D., Non-Executive Independent Director
  • Alicia Secor, Non-Executive Independent Director

How do I buy shares of GW Pharmaceuticals?

Shares of GWP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GW Pharmaceuticals' official website?

The official website for GW Pharmaceuticals is http://www.gwpharm.com/.

How can I contact GW Pharmaceuticals?

GW Pharmaceuticals' mailing address is Sovereign House, Vision Park, CAMBRIDGE, 00000, United Kingdom. The biopharmaceutical company can be reached via phone at +44-1223-266800.

MarketBeat Community Rating for GW Pharmaceuticals (LON GWP)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  71 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about GW Pharmaceuticals and other stocks. Vote "Outperform" if you believe GWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel